T1	intervention 30 38	carmofur
T2	total-participants 161 164	150
T3	eligibility 165 224	patients with breast cancer of T0N1, T1, N1, T2N0, and T2N1
T4	intervention-participants 244 247	100
T5	control-participants 265 267	50
T6	control 272 282	carboquone
T8	outcome 437 453	Overall survival
T9	iv-bin-percent 492 495	90%
T10	cv-bin-percent 523 526	88%
T11	outcome 636 651	Leukocyte count
T12	iv-bin-abs 768 769	5
T13	cv-bin-abs 787 788	5
T14	outcome 819 836	second malignancy
